The ASH Workshop on Genome Editing was held July 14-15, 2016, at the Omni Shoreham Hotel in Washington, DC. The workshop brought together more than 150 clinical and laboratory-based scientists, funders, and regulators to share cutting-edge research and tackle key scientific and clinical hurdles in the field of genome editing. Recognizing the potential of genome editing to correct genetic flaws, ASH has made developing this emerging technology a research priority in recent years.
The ASH Workshop on Genome Editing covered a broad swath of the genome editing landscape, including contemporary laboratory applications, burgeoning therapeutic potential, and regulatory considerations for such therapies. It provided networking opportunities between academicians, industry scientists, government officials, and others in the field in order to foster partnerships that can strengthen the discovery-approval-application pipeline for current and emerging genome editing processes.
Mitchell Weiss, MD, PhD
St. Jude Children’s Research Hospital, Memphis, TN
J. Keith Joung, MD, PhD
Massachusetts General Hospital and Harvard Medical School, Boston, MA
Philip Gregory, DPhil
bluebird bio, Inc., Cambridge, MA
For more information about the meeting, please contact ASH Scientific Programs Coordinator, Karina Ngaiza, MA, at email@example.com.
back to top